Category Archives: Eczema

~ Gadgeteers #39; Nanocurrents invention clears health food store owner #39;s allergy or eczema in one hour

By: windows03

Here is the original post:
~ Gadgeteers' Nanocurrents invention clears health food store owner's allergy or eczema in one hour - Video

Eczema - Mi Viejo Costurero (Inmaculada 2013)
Presentación del tema "Mi Viejo Costurero" del grupo valdiviano Eczema en el II Festival Interescolar de Bandas Inmaculada Concepción 2013.

By: Juanca Escobar

Go here to read the rest:
Eczema - Mi Viejo Costurero (Inmaculada 2013) - Video

Eczema - El Tipo de las Cartas (Inmaculada 2013)
Presentación del tema "El Tipo de las Cartas" del grupo valdiviano Eczema en el II Festival Interescolar de Bandas Inmaculada Concepción 2013.

By: Juanca Escobar

Go here to see the original:
Eczema - El Tipo de las Cartas (Inmaculada 2013) - Video

Eczema - Mix No Lo Tomes Personal (Inmaculada 2013)

By: Juanca Escobar

See more here:
Eczema - Mix No Lo Tomes Personal (Inmaculada 2013) - Video

MEMPHIS, Tenn., Oct. 3, 2013 /PRNewswire/ --The Theraplex Company announced today that it has introduced two new product additions to its line of medical moisturizers. The introduction of Theraplex Eczema Therapy and Theraplex Barrier Balm coincides with Eczema Awareness Month.

In more recent years, the treatment of eczema has become a particular focus for the company. "We received the most heartwarming testimonials from eczema sufferers telling us how Theraplex had truly changed their lives," said Mike Pietrangelo, Managing Partner of The Theraplex Company, LLC. "We became associated with the National Eczema Association, about five years ago, and it opened our eyes to the needs of eczema patients and their families." The uncomplicated, non-irritating, hypoallergenic nature of the Theraplex formulations makes the line ideal for individuals with extremely dry and sensitive skin. Two of the line's original products, Theraplex ClearLotion and Theraplex Emollient, received the National Eczema Association Seal of Acceptance and received their highest rating possible-- 5 out of 5. Theraplex Eczema Therapy and Theraplex Barrier Balm have been awarded the seal as well.

Theraplex Eczema Therapy adds colloidal oatmeal to its highly refined, fractioned petrolatum to create a soothing moisturizer, which penetrates deep into the skin's surface to provide superior hydration and skin barrier protection for hours. Colloidal oatmeal, the active ingredient in Theraplex Eczema Therapy, acts as a skin protectant to help provide long lasting barrier protection to dry, compromised skin.

Theraplex Barrier Balm is a softer version of the original Theraplex Emollient. The lighter formulation allows it to more quickly penetrate the skin's surface while providing the same level of continual moisturization and skin protection.

Both new products contain a special petrolatum fraction, a unique process by which over 80% of the heavy oils and greases are extracted from the petrolatum. This process results in far less tackiness than is typically associated with other petrolatum-based products. Both Eczema Therapy and Barrier Balm are noncomedogenic and free of parabens, preservatives and fragrances.

The Theraplex line of over-the-counter moisturizers and facial chemical peels has been recommended by dermatologists to patients suffering from various dry skin conditions for more than 20 years.

Theraplex Eczema Therapy and Theraplex Barrier Balm are currently available exclusively through the company's website: http://www.theraplex.com. During the month of October, Theraplex will honor Eczema Awareness Month by offering special pricing on its products for eczema, with a portion of the proceeds going to the National Eczema Association.

Read more from the original source:
The Theraplex Company Introduces New Products for Eczema

BERKELEY

Some 10 percent of the population suffers from eczema at some point in their lives. The chronic skin condition, for which there are no cures or good treatments, causes symptoms ranging from dry, flaky and itchy skin to flaming red rashes and, particularly in children, nasal allergies and asthma.

Scientists at the University of California, Berkeley, have developed a new picture of how the nervous system interacts with the immune system to cause the itch and inflammation associated with eczema. Their findings could lead to new therapies for the disease.

Eczemas cause is unknown, but most research today focuses on the immune systems role in reacting to chemicals that cause itching and inflammation. UC Berkeley neuroscientist Diana M. Bautista and graduate students Sarah R. Wilson and Lydia Th, however, discovered that sensory nerves in the skin are the first to react to these chemicals, and that blocking the skins itch receptors not only stops the scratching, but may head off the worst consequences of eczema.

Most drug development has focused on trying to find a way to inhibit the immune response, said Bautista, assistant professor of molecular and cell biology and a member of the Helen Wills Neuroscience Institute. Now that we have found that sensory neurons may be the first responders, that changes how we think about the disease.

By just blocking what is happening in the neurons, you could block the symptoms of chronic itch, including the big immune response leading to asthma and allergy, Wilson added. And you prevent the patient from scratching, which damages skin cells and makes them release more chemicals that cause inflammation and help maintain chronic itch.

The researchers already have identified a potential drug, now in Phase 1 clinical trials for a different inflammatory disease, that stops mice from scratching when it is applied to the skin.

Their new model of eczema is based on findings reported online today (Thursday, Oct. 3) in the journal Cell by Bautista, Wilson, Th and their UC Berkeley colleagues.

Block that wasabi We started out looking at acute itch and asked the question, Why do we scratch? Why do we have that urge, and how does it work that scratching gives you some relief, when normally it feels terrible if you dont have an itch and scratch yourself that hard? Bautista said. But the many types of chronic itch that humans experience are all very different. We believe that, through identifying molecular mechanisms, we can find new treatments and therapies for these diseases.

Immunologists several years ago identified a chemical TSLP (thymic stromal lymphopoietin), a so-called cytokine that induces itch when expressed in the skin. Because immune cells have receptors for this chemical, TSLP triggers them to release chemicals that attract other immune cells and to create the red, itchy inflammation typical of eczema. These inflammatory chemicals seem to spread through the body and induce inflammation in the lungs, gut and nasal passages that lead to asthma and allergies, Bautista said.

Read more:
Blocking nerve cells could halt symptoms of eczema

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/thjp9l/disease_and) has announced the addition of the "Disease and Therapy Review: Eczema" report to their offering.

The Eczema Disease and Therapy Review provides an overview of eczema, with prevalence numbers (pediatric and total), percentages and trends for major countries worldwide, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the eczema market, as well as sales of leading drugs and therapies are provided.

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the authors' senior market research team of. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends.

The data contained in these reports comes from key industry secondary data sources, such as the authors Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.

Key Topics Covered:

I. OVERVIEW

II. PREVALENCE

III. DIAGNOSIS

IV. TREATMENT

View original post here:
Research and Markets: Disease and Therapy Review: Eczema

Cure For Facial Dry Skin Eczema.mp4
Cure For Facial Dry Skin Eczema.acne,mrsa,dermatolo,Cyst,kill,Sebaceous,Really Bad Spider Bite,Cleaning face injury infection with plastic needle,Extraction ...

By: Kara Karam

Read this article:
Cure For Facial Dry Skin Eczema.mp4 - Video

Home Remedies for Eczema - Eczema Treatment (How to get Rid of Eczema!)
Home Remedies for Eczema http://www.besthomeremediesforeczema.com/eczema-free If you #39;re like me, then you hate your eczema. Well then, you #39;ll probably be exc...

By: Lucia Flores

Link:
Home Remedies for Eczema - Eczema Treatment (How to get Rid of Eczema!) - Video

Atopic eczema, children learning to apply the cream - La Roche-Posay (SST)
Discover the video of children with eczema. Laetitia Coirier, educator at the chalet Lipi Kara, shows them how to apply the cream. First cheeks and forehea...

By: Larocheposayinter

More:
Atopic eczema, children learning to apply the cream - La Roche-Posay (SST) - Video